Indoco Remedies Overview

  • Year Founded
  • 1945

Year Founded

  • Status
  • Public

  • Employees
  • 5,744

Employees

  • Stock Symbol
  • 532612

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $2.43
  • (As of Friday Closing)

Indoco Remedies General Information

Description

Indoco Remedies Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The company has only one business segment i.e Pharmaceutical Products. The company generates majority of revenue from India.

Contact Information

Website
www.indoco.com
Formerly Known As
Indo-Continental Trading Company
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Indoco House
  • 166 CST Road, Santacruz (East)
  • Mumbai, Maharashtra 400098
  • India
+91 022
Primary Industry
Drug Discovery
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Indoco House
  • 166 CST Road, Santacruz (East)
  • Mumbai, Maharashtra 400098
  • India
+91 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Indoco Remedies Stock Performance

As of 13-Nov-2026, Indoco Remedies’s stock price is $2.43. Its current market cap is $224M with 92.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.43 $2.44 $1.73 - $3.05 $224M 92.2M 38.9K $0.04

Indoco Remedies Financials Summary

As of 30-Sep-2026, Indoco Remedies has a trailing 12-month revenue of $201M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 362,235 262,643 343,157 412,872
Revenue 200,971 202,905 194,104 216,005
EBITDA 32,986 10,348 11,904 31,242
Net Income 3,446 (10,766) (8,720) 11,893
Total Assets 272,015 274,849 284,070 257,182
Total Debt 110,273 115,497 116,153 80,576
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Indoco Remedies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Indoco Remedies‘s full profile, request access.

Request a free trial

Indoco Remedies Patents

Indoco Remedies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250073162-A1 A stable injectable composition of triamcinolone acetonide Pending 17-Mar-2022
WO-2023175420-A1 A stable injectable composition of triamcinolone acetonide Inactive 17-Mar-2022
WO-2022195382-A1 A stable ophthalmic nanosupension of brinzolamide Inactive 19-Mar-2021
WO-2022023822-A1 A stable ophthalmic composition of posaconazole Inactive 30-Jul-2020
WO-2019073481-A1 Process for the preparation of brexpiprazole and its intermediates Inactive 12-Oct-2017 C07D409/12
To view Indoco Remedies’s complete patent history, request access »

Indoco Remedies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Indoco Remedies Investments & Acquisitions (6)

Indoco Remedies’s most recent deal was a Merger/Acquisition with Florida Pharmaceutical Products for . The deal was made on 06-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Florida Pharmaceutical Products 06-Jun-2023 Merger/Acquisition Pharmaceuticals
Jalansar Wind Energy 30-Sep-2022 Secondary Transaction - Private Special Purpose Acquisition Company (SPAC)
Micro Labs (Pharmaceutical Plant Baddi) 21-Sep-2016 Corporate Asset Purchase Buildings and Property
Piramal (clinical research division) 06-Apr-2015 Merger/Acquisition Laboratory Services (Healthcare)
La Nova Chem 04-Jul-2006 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Indoco Remedies ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

35.87 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Indoco Remedies’s complete esg history, request access »

Indoco Remedies Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Florida Pharmaceutical Products Boca Raton, FL 1999

Indoco Remedies FAQs

  • When was Indoco Remedies founded?

    Indoco Remedies was founded in 1945.

  • Where is Indoco Remedies headquartered?

    Indoco Remedies is headquartered in Mumbai, India.

  • What is the size of Indoco Remedies?

    Indoco Remedies has 5,744 total employees.

  • What industry is Indoco Remedies in?

    Indoco Remedies’s primary industry is Drug Discovery.

  • Is Indoco Remedies a private or public company?

    Indoco Remedies is a Public company.

  • What is Indoco Remedies’s stock symbol?

    The ticker symbol for Indoco Remedies is 532612.

  • What is the current stock price of Indoco Remedies?

    As of 13-Nov-2026 the stock price of Indoco Remedies is $2.43.

  • What is the current market cap of Indoco Remedies?

    The current market capitalization of Indoco Remedies is $224M.

  • What is Indoco Remedies’s current revenue?

    The trailing twelve month revenue for Indoco Remedies is $201M.

  • What is Indoco Remedies’s annual earnings per share (EPS)?

    Indoco Remedies’s EPS for 12 months was $0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process